Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from TrivarX Limited ( (AU:TRI) ) is now available.
TrivarX Limited has issued over 2.4 million ordinary fully paid shares to settle consulting fees, with shares priced between $0.011 and $0.017 each. This issuance was conducted without disclosure to investors under the Corporations Act, and the company confirms compliance with relevant provisions, ensuring no excluded information affects investor assessments.
More about TrivarX Limited
TrivarX Limited is a mental health technology company focused on pioneering the use of objective measures for early detection and screening of mental health conditions. Founded in Australia, it operates from offices in Perth and Minneapolis and is listed on the Australian Securities Exchange and trades on the OTCQB Venture Market.
Average Trading Volume: 1,380,042
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$6.17M
See more data about TRI stock on TipRanks’ Stock Analysis page.